• Ashraf U, Benoit-Pilven C, Lacroix V, Navratil V, Naffakh N. 2019. Advances in analyzing virus-induced alterations of host cell splicing. Trends Microbiol. 27, 268-281.

  • Bonenfant G, Meng R, Shotwell C, Badu P, Payne AF, Ciota AT, Sammons MA, Berglund JA, Pager CT. 2020. Asian Zika virus isolate significantly changes the transcriptional profile and alternative RNA splicing events in a neuroblastoma cell line. Viruses 12, 510.

  • Duriez M, Mandouri Y, Lekbaby B, Wang H, Schnuriger A, Redelsperger F, Guerrera CI, Lefevre M, Fauveau V, Ahodantin J, Quetier I, Chhuon C, Gourari S, Boissonnas A, Gill U, Kennedy P, Debzi N, Sitterlin D, Maini MK, Kremsdorf D, Soussan P. 2017. Alternative splicing of hepatitis B virus:A novel virus/host interaction altering liver immunity. J Hepatol. 67, 687-699.

  • Galbraith MD, Kinning KT, Sullivan KD, Baxter R, Araya P, Jordan KR, Russell S, Smith KP, Granrath RE, Shaw JR, Dzieciatkowska M, Ghosh T, Monte AA, D'Alessandro A, Hansen KC, Benett TD, Hsieh EW, Espinosa JM. 2021. Seroconversion stages COVID19 into distinct pathophysiological states. Elife 10, e65508.

  • julian.knight@well.ox.ac.uk CO-M-oBACEa, Consortium CO-M-oBA. 2022. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell 185, 916-938.e958.

  • Kremsdorf D, Lekbaby B, Bablon P, Sotty J, Augustin J, Schnuriger A, Pol J, Soussan P. 2021. Alternative splicing of viral transcripts:The dark side of HBV. Gut 70, 2373-2382.

  • Lee Y, Rio DC. 2015. Mechanisms and regulation of alternative pre-mrna splicing. Annu Rev Biochem, 84:291-323.

  • Li D, Su M, Sun PP, Guo WP, Wang CY, Wang JL, Wang H, Zhang Q, Du LY, Xie GC. 2020. Global profiling of the alternative splicing landscape reveals transcriptomic diversity during the early phase of enterovirus 71 infection. Virology 548, 213-225.

  • Lin W, Zhu C, Hong J, Zhao L, Jilg N, Fusco DN, Schaefer EA, Brisac C, Liu X, Peng LF, Xu Q, Chung RT. 2015. The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing. J Hepatol, 62:1024-1032.

  • McClain MT, Constantine FJ, Henao R, Liu Y, Tsalik EL, Burke TW, Steinbrink JM, Petzold E, Nicholson BP, Rolfe R, Kraft BD, Kelly MS, Saban DR, Yu C, Shen X, Ko EM, Sempowski GD, Denny TN, Ginsburg GS, Woods CW. 2021. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery. Nat Commun.12, 1079.

  • Pozzi B, Bragado L, Mammi P, Torti MF, Gaioli N, Gebhard LG, Garcia Sola ME, Vaz-Drago R, Iglesias NG, Garcia CC, Gamarnik AV, Srebrow A. 2020. Dengue virus targets RBM10 deregulating host cell splicing and innate immune response. Nucleic Acids Res. 48, 6824-6838.

  • Tomezsko PJ, Corbin VDA, Gupta P, Swaminathan H, Glasgow M, Persad S, Edwards MD, McIntosh L, Papenfuss AT, Emery A, Swanstrom R, Zang T, Lan TCT, Bieniasz P, Kuritzkes DR, Tsibris A, Rouskin S. 2020. Determination of RNA structural diversity and its role in HIV-1 rna splicing. Nature 582,438-442.

  • Wang LY, Balmat TJ, Antonia AL, Constantine FJ, Henao R, Burke TW, Ingham A, McClain MT, Tsalik EL, Ko ER, Ginsburg GS, DeLong MR, Shen XL, Woods CW, Hauser ER, Ko DC. 2021. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility. Genome Medicine 13, 83.

  • Wu P, Chen D, Ding W, Wu P, Hou H, Bai Y, Zhou Y, Li K, Xiang S, Liu P, Ju J, Guo E, Liu J, Yang B, Fan J, He L, Sun Z, Feng L, Wang J, Wu T, Wang H, Cheng J, Xing H, Meng Y, Li Y, Zhang Y, Luo H, Xie G, Lan X, Tao Y, Li J, Yuan H, Huang K, Sun W, Qian X, Li Z, Huang M, Ding P, Wang H, Qiu J, Wang F, Wang S, Zhu J, Ding X, Chai C, Liang L, Wang X, Luo L, Sun Y, Yang Y, Zhuang Z, Li T, Tian L, Zhang S, Zhu L, Chang A, Chen L, Wu Y, Ma X, Chen F, Ren Y, Xu X, Liu S, Wang J, Yang H, Wang L, Sun C, Ma D, Jin X, Chen G. 2021. The trans-omics landscape of COVID-19. Nat Commun. 12, 4543.

  • Zheng HY, Xu M, Yang CX, Tian RR, Zhang M, Li JJ, Wang XC, Ding ZL, Li GM, Li XL, He YQ, Dong XQ, Yao YG, Zheng YT. 2020. Longitudinal transcriptome analyses show robust t cell immunity during recovery from COVID-19. Signal Transduct Target Ther. 5, 294.